CPI-613 Uses, Dosage, Side Effects and more
CPI-613 has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Advanced Cancer, and Pancreatic Cancer, among others.
| Attribute | Details |
|---|---|
| Trade Name | CPI-613 |
| Generic | CPI-613 |
| Type | |
| Formula | C22H28O2S2 |
| Weight | Average: 388.58 Monoisotopic: 388.15307249 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
